LSA
SAGE

Leonteq Securities AG’s Sage Therapeutics SAGE Stock Holding History

Leonteq Securities AG’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,100
Closed -$98.7K – 1281
2023
Q2 		$98.7K Buy
2,100
+1,600
+320% +$79.6K 0.01% 677
2023
Q1 		$21K Hold
500
– – ﹤0.01% 924
2022
Q4 		$19.1K Sell
500
-300
-38% -$11.5K ﹤0.01% 971
2022
Q3 		$31.3K Sell
800
-500
-38% -$19.3K ﹤0.01% 894
2022
Q2 		$42K Buy
1,300
+100
+8% +$3.35K ﹤0.01% 865
2022
Q1 		$39.7K Sell
1,200
-100
-8% -$3.76K ﹤0.01% 906
2021
Q4 		$55.3K Buy
1,300
+700
+117% +$29.3K ﹤0.01% 889
2021
Q3 		$26.6K Sell
600
-225
-27% -$10.3K ﹤0.01% 931
2021
Q2 		$46.9K Buy
825
+450
+120% +$31.8K ﹤0.01% 843
2021
Q1 		$28.1K Sell
375
-625
-63% -$51.2K ﹤0.01% 842
2020
Q4 		$86.5K Buy
+1,000
New +$73.7K ﹤0.01% 703

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's SAGE Position: Q3 2023 in Review

Leonteq Securities AG sold out of Sage Therapeutics (SAGE) in Q3 2023, closing a stake of 2,100 shares — an estimated $98.7K sold.

Leonteq Securities AG first reported a position in SAGE in Q4 2020 and held it in 11 quarters. The position peaked at $98.7K in Q2 2023. 194 funds tracked by Wall St. Rank hold SAGE as of Q3 2023.

  • Leonteq Securities AG reported no remaining Sage Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 2,100 Sage Therapeutics shares in Q3 2023, an estimated $98.7K.
  • Leonteq Securities AG first reported a position in Sage Therapeutics in Q4 2020 and held it in 11 quarters.
  • Leonteq Securities AG's Sage Therapeutics position peaked at $98.7K in Q2 2023.
  • 194 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.